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each condition were performed on 4 test/control pairs for both
cB and cAC.
To verify that the cB removed a significant amount of the DS,
specimens were cut into 14 sections, 7 in a top half layer and
7 in a bottom half layer, and Western blot analysis for the
decorin protein performed on each section. For comparison, cAC
specimens were cut in a similar fashion and total proteoglycans
assayed with the DMB assay.
Results: cB had no detectable effect on rapid modulus, equilib-
rium modulus, or relaxation function in indentation. Conversely,
cAC caused reduction in equilibrium modulus and relaxation
function, consistent with published work of others. Approximately
one-half of the DS was removed from the top layer. Assay of the
cAC specimens for total proteoglycan showed similar digestion
patterns, suggesting that the two enzymes acted similarly.
Conclusions: Removal of DS from the cartilage did not affect
the viscoelastic properties of the cartilage, indicating that decorin
is not a structural molecule in cartilage in indentation.
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Purpose: There is growing recognition that environmental fac-
tors may play a significant role in determining the health of
musculoskeletal tissues, including cartilage. Many of the cellu-
lar mechanisms that contribute to cartilage catabolism such as
oxidative stress, altered growth factor signaling, matrix mineral-
ization and activation of metaloproteinases can be initiated by
heavy metal toxicants. The aim of this study was to determine
if heavy metal toxicants activate chondrocyte mitogen-activated
protein kinases (MAPKs) that can then lead to altered cartilage
homeostasis.
Methods: Chondrocytes were enzymatically isolated from com-
mercially obtained 4-6 month-old porcine knee joints (approved
by the UNC IACUC) by sequential digestion in pronase and
collagenase, and grown in high-density monolayer culture (105
cells/cm2). Cultures were serum-starved overnight and subse-
quently treated with organic methylmercury (MeHg), inorganic
mercuric chloride (HgCl2), or lead acetate (PbAc), for up to 60
minutes at varying concentrations prior to cell extraction with
ice-cold lysis buffer. Additional cultured were treated with IL-1.
Activation of MAPKs was determined by western blotting using
phosphorylation-specific polyclonal antibodies.
Results: MeHg and caused transient activation of JNK at con-
centrations as low as 1uM, though the degree of activation by
MeHg was lower than by IL-1. Maximal activation occured at
10 minutes, returning to baseline levels within 30 minutes. p38
MAPK was activated by IL-1, but not MeHg or HgCl2, within this
time frame. HgCl2 and PbAc treatments also caused transient
activation of JNK, with maximal activation at 10 minutes.
Conclusions: Environmental toxicants are recognized as con-
tributing factors in many chronic human diseases. This study
demonstrates that environmental heavy metals activate JNK in
articular chondrocytes and suggests that metals may influence
the rate or severity of osteoarthritis through modulation of intra-
cellular signaling pathways.
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Purpose: Pomegranate fruit (Punica granatum L) is revered
through the ages for its medicinal properties. Pomegranate fruit
(PF) or its extract (PFE) is widely used in Asian and Mediter-
ranean cultures for the treatment of inflammation, for pain in
arthritis and other diseases. Osteoarthritis (OA) is the most
common musculoskeletal disease among the aging population.
Pro-inflammatory cytokine IL-1β plays a dominant role in OA
pathogenesis which is characterized by degeneration of articular
cartilage of the joints in hands, knees, spine and hips. We have
evaluated the effects of a standardized PFE preparation on hu-
man OA cartilage and OA chondrocytes treated with IL-1β with a
view to determining whether consumption of PF or PFE can be
useful in preventing joint cartilage degradation in OA.
Methods: Human cartilage and synovial fluid (SF) were obtained
at the time of hip arthroplasty. Cartilage explants were prepared
by standard methods and chondrocytes were liberated by en-
zymatic dissociation from femoral heads. Cartilage explants or
chondrocytes were treated with IL-1β (5 ng/ml) or IL-1β and
PFE (10 - 200 μg/ml) using previously described methods. The
effect of PFE on IL-1β-induced apoptosis in chondrocytes was
determined by viability assays and Western blotting. Substrate-
embedded enzymography and/or collagen degradation assays
were used to characterize the MMP activity in conditioned me-
dia and SF. Western immunoblotting and immunoprecipitation
was used to confirm the presence and/or interaction of specific
proteins in the SF and conditioned media. Quantitative RT-PCR
was employed to quantify MMP mRNA expression levels. Human
chondrocyte nucleofection with reporter constructs was used to
analyze the effect of PFE on IL-1β-induced gene promoter activ-
ity. Cartilage explants were stained with Safranin-O/Fast Green.
Matrix proteoglycan and collagen degradation was determined
in culture supernatant using metachromatic assays. The results
were analyzed using the Student-t test where p<0.05 was con-
sidered significant.
Results: PFE at the concentrations used was found to be non-
toxic and remarkably effective in inhibiting IL-1β-induced human
chondrocyte apoptosis. PFE also blocked the gelatinolytic ac-
tivities of recombinant human MMPs as well as MMP activity
recovered from SF of OA patients. Quantitative zymography
also showed that in IL-1β-stimulated human chondrocytes cul-
tures pretreated with PFE the substrate degrading activity of
MMP-9 and MMP-13 was significantly lower (p <0.05). Western
immunoblotting showed that IL-1β-induced protein expression
of MMP-9 and MMP-13 was inhibited when human chondro-
cytes were pre-treated with PFE. Quantitative RT-PCR showed
that PFE blocked MMP-9 and MMP-13 mRNA expression. Fur-
thermore, PFE inhibited IL-1β-induced MMP-9 and -13 gene
promoter activity (p <0.005) in transfected human chondrocytes
indicating that PFE was acting at the level of transcription.
Histochemical and biochemical analysis of human cartilage ex-
plants showed that the proteoglycan and Type-II collagen content
loss was significantly less (p <0.05) in cartilage explants when
PFE was present during IL-1β stimulation or when activated re-
combinant MMPs were exogenously added to explant cultures
pretreated with PFE. Chondrocytes cultured in the presence of
PFE also showed increased proteoglycan and collagen synthe-
sis. PFE also blocked the IL-1β-induced loss and inhibition of
matrix synthesis.
Conclusions: Our results indicated that PFE blocked the IL-1β-
induced human cartilage degradation and MMP-9 and MMP-13
